Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-26 @ 1:13 AM
Study NCT ID:
NCT03464734
Status:
COMPLETED
Last Update Posted:
2022-11-30
First Post:
2018-02-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-16
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-21
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-19
First Submit QC Date:
None
Study First Post Date:
2018-03-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-24
Last Update Post Date:
2022-11-30
Last Update Post Date Type:
ACTUAL